Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New WhatsApp-Based program aims to boost HIV prevention among young women in ghana

NCT ID NCT07003789

Prevention Sponsor: State University of New York at Buffalo Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is creating a women-centered HIV prevention program for young women aged 18-35 in Ghana. The program uses WhatsApp and community workshops to provide information on HIV self-testing and PrEP, aiming to reduce stigma and increase prevention uptake. Researchers will test the program with 50 women to see if it is acceptable and easy to use.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Women-Centered HIV Prevention Program (behavioral intervention via WhatsApp and workshops)
What this could lead to
If successful, this could provide a scalable, youth-friendly model to reduce HIV stigma and increase use of HIV self-testing and PrEP among young women in Ghana.
What could go wrong
This is a small, early feasibility study with only 50 participants, so results may not apply broadly. The intervention relies on WhatsApp and group workshops, which may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 65 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 35 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Identify as female and be between 18-35 years of age Reside in Greater Accra or the Eastern Region of Ghana Be sexually active (defined as having engaged in vaginal, anal, or oral sex in the past 6 months) Have access to a mobile phone with WhatsApp Be willing to provide informed consent Be interested in participating in HIV prevention activities Be comfortable discussing sexual and reproductive health in a group setting (for the workshop) For pilot phase only: must not have participated in the co-development workshop Exclusion Criteria: Do not reside in the two specified regions of Ghana Unable to provide informed consent Have cognitive impairments or severe mental health conditions limiting participation Community partners with commercial conflicts of interest (for workshop only)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV prevention are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Coitus HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV prevention Sexual and reproductive health Women's health

Contacts and locations

Locations

  • EARC

    Accra, Ghana

More trials for these conditions

Other studies related to the condition(s) this trial covers.